syaddana_neuro Profile Banner
Sridhara S Yaddanapudi MD Profile
Sridhara S Yaddanapudi MD

@syaddana_neuro

Followers
3K
Following
3K
Statuses
2K

#vascular neurology #Hypertension #Neurohospitalist l creator neurology quiz l assistant prof Thomas Jefferson l posts/opinions = my own

Philadelphia, PA
Joined February 2011
Don't wanna be here? Send us removal request.
@syaddana_neuro
Sridhara S Yaddanapudi MD
4 years
1/3Always consider cancer screening in cryptogenic strokes. The following are important handles/red flags- smoking hx, unexplained weight loss. Labs showing unexplained anemia, elevated d-dimer. Imaging - three territory or large vessel strokes #MedTwitter #neurotwitter #stroke
2
1
22
@syaddana_neuro
Sridhara S Yaddanapudi MD
3 days
RT @StrokeAHA_ASA: 🧵#STROKE Simultaneous publication at #ISC25 🔴 In tandem occlusion patients secondary to cervical carotid artery dissecti…
0
29
0
@syaddana_neuro
Sridhara S Yaddanapudi MD
5 days
RT @MarcusVPinto: Amyloid neuropathies are treatable and should not be missed. @gabifpucci and I updated the @neudrawlogy amyloid neuropath…
0
83
0
@syaddana_neuro
Sridhara S Yaddanapudi MD
6 days
Identify trial - early Bp lowering after Endovascular treatment within 6 hours of onset did not improve outcomes- more cardioembolic patients and only 10 mm hg difference between both arms ⁦@StrokeAHA_ASA#ISC25
Tweet media one
0
1
9
@syaddana_neuro
Sridhara S Yaddanapudi MD
6 days
Transcranial direct current stimulation not beneficial in upper limb motor recovery of stroke. Back to the drawing board !! ⁦@StrokeAHA_ASA#ISC25
Tweet media one
0
3
18
@syaddana_neuro
Sridhara S Yaddanapudi MD
7 days
Bentracimab reversal agent for Ticagrelor !! Reverse it trial results are pending but exciting development ⁦@StrokeAHA_ASA#ISC25
Tweet media one
0
2
12
@syaddana_neuro
Sridhara S Yaddanapudi MD
7 days
@SBAVC1 @StrokeAHA_ASA Not necessarily!! Just means we have to figure out which sub population benefits.
0
0
0
@syaddana_neuro
Sridhara S Yaddanapudi MD
7 days
Discount DeVo another negative trial stopped early due to futility for evt !! ⁦@StrokeAHA_ASA#isc25
Tweet media one
0
1
8
@syaddana_neuro
Sridhara S Yaddanapudi MD
7 days
Escape MeVo negative no benefit to evt. Not the end but helps design future trials !! ⁦@StrokeAHA_ASA#isc25
Tweet media one
0
1
5
@syaddana_neuro
Sridhara S Yaddanapudi MD
7 days
Transradial not shown to be equivalent to transfemoral angiography approach mainly due to radial artery vasospasm leading to longer procedure time and slightly higher failure rates ⁦@StrokeAHA_ASA#isc25
Tweet media one
0
0
2
@syaddana_neuro
Sridhara S Yaddanapudi MD
7 days
Stopped early due to Enrich trial. 24 hours to intervention. 30 days benefit >> but not at 90 or 180 days
0
0
1
@syaddana_neuro
Sridhara S Yaddanapudi MD
8 days
Walking through doorways causes forgetting: Further explorations - PubMed - ever wonder why you walk into a room and forget what you wanted to do ? It has to do with our brains encoding specific memories to specific rooms
0
0
8
@syaddana_neuro
Sridhara S Yaddanapudi MD
10 days
RT @NeuroWalid: Differences in MRI imaging FLAIR. #neurotip #neuroimaging
Tweet media one
0
48
0
@syaddana_neuro
Sridhara S Yaddanapudi MD
12 days
Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities | American Journal of Neuroradiology ⁦@StrokeAHA_ASA⁩ ⁦@AANmember
0
0
2
@syaddana_neuro
Sridhara S Yaddanapudi MD
13 days
:: Journal of Stroke Neurovascular Complications of Acute Aortic Syndrome ⁦@StrokeAHA_ASA
0
3
9
@syaddana_neuro
Sridhara S Yaddanapudi MD
15 days
0
0
1